IL216649A0 - Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide - Google Patents
Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamideInfo
- Publication number
- IL216649A0 IL216649A0 IL216649A IL21664911A IL216649A0 IL 216649 A0 IL216649 A0 IL 216649A0 IL 216649 A IL216649 A IL 216649A IL 21664911 A IL21664911 A IL 21664911A IL 216649 A0 IL216649 A0 IL 216649A0
- Authority
- IL
- Israel
- Prior art keywords
- carbamoylamino
- polymorphs
- carboxamide
- phenoxy
- trifluoromethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1395CH2009 | 2009-06-12 | ||
| PCT/EP2010/058006 WO2010142678A2 (en) | 2009-06-12 | 2010-06-08 | Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL216649A0 true IL216649A0 (en) | 2012-02-29 |
Family
ID=42931997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL216649A IL216649A0 (en) | 2009-06-12 | 2011-11-28 | Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2440531A2 (de) |
| IL (1) | IL216649A0 (de) |
| WO (1) | WO2010142678A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2775296A1 (en) | 2009-09-24 | 2011-03-31 | Ranbaxy Laboratories Limited | Polymorphs of sorafenib acid addition salts |
| WO2012071425A1 (en) | 2010-11-22 | 2012-05-31 | Teva Pharmaceutical Industries Ltd. | Solid state forms of sorafenib besylate, and processes for preparations thereof |
| WO2013175506A2 (en) * | 2012-05-21 | 2013-11-28 | Hetero Research Foundation | Process for sorafenib tosylate polymorph iii |
| EP2922820A4 (de) * | 2012-05-23 | 2016-06-01 | Shilpa Medicare Ltd | Verfahren zur herstellung von kristallinem sorafenib-tosylat |
| CN103570613B (zh) * | 2012-07-18 | 2016-06-15 | 苏州泽璟生物制药有限公司 | 氘代ω-二苯基脲或其盐的多晶型物 |
| CN106336377A (zh) * | 2015-07-17 | 2017-01-18 | 苏州亚宝药物研发有限公司 | 一种甲苯磺酸索拉非尼晶型ⅱ的制备方法 |
| EP3390362A4 (de) * | 2015-12-14 | 2019-06-26 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Sorafenib-hemi-p-tosylat-monohydrat-kristall und herstellungsverfahren dafür |
| CN107759517A (zh) * | 2016-08-23 | 2018-03-06 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种甲苯磺酸索拉非尼晶型ⅰ的制备方法 |
| RU2766288C2 (ru) * | 2020-03-30 | 2022-03-11 | Общество с ограниченной ответственностью "АКСЕЛЬФАРМ" | Аморфная форма 4-{ 4-[({ [4-хлор-3-(трифторметил)фенил]амино} карбонил)-амино]фенокси} -n-метилпиридин-2-карбоксамида тозилата (варианты), способ её получения и применение для лечения онкологических заболеваний |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006026501A1 (en) * | 2004-08-27 | 2006-03-09 | Bayer Pharmaceuticals Corporation | New pharmaceutical compositions for the treatment of cancer |
| BRPI0515946A (pt) * | 2004-09-29 | 2008-08-12 | Bayer Healthcare Ag | sal de tosilato, sua preparação e uso, bem como composição farmacêutica compreendendo o mesmo |
| JP5304241B2 (ja) * | 2005-03-07 | 2013-10-02 | バイエル・ヘルスケア・エルエルシー | 癌の処置用のオメガ−カルボキシアリール置換ジフェニルウレアを含む医薬組成物 |
| US20070088508A1 (en) * | 2005-09-28 | 2007-04-19 | Scott Childs | Cocrystallization methods |
| CA2657379A1 (en) * | 2006-07-10 | 2008-01-17 | Elan Pharma International Ltd. | Nanoparticulate sorafenib formulations |
| WO2009106825A1 (en) * | 2008-02-27 | 2009-09-03 | Cipla Limited | Polymorphs of sorafenib and salts thereof |
| CN101584661B (zh) * | 2009-06-10 | 2011-06-08 | 北京大学 | 一种供口服或静脉注射用索拉非尼自微乳化给药系统及其制备方法 |
-
2010
- 2010-06-08 WO PCT/EP2010/058006 patent/WO2010142678A2/en active Application Filing
- 2010-06-08 EP EP10722711.8A patent/EP2440531A2/de not_active Withdrawn
-
2011
- 2011-11-28 IL IL216649A patent/IL216649A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010142678A2 (en) | 2010-12-16 |
| WO2010142678A3 (en) | 2011-03-24 |
| EP2440531A2 (de) | 2012-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL216649A0 (en) | Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide | |
| HK1223819A1 (zh) | 鹵代烷基雜芳基苯甲酰胺化合物 | |
| HK1136287A1 (en) | 4-[4-([4-chloro-3-(trifluoromethyl)phenyl)]carbamoylamino)-3- fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate 4-[4-([4--3-())])-3-]-n--2- | |
| HK1183014A1 (en) | Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide 6--3--2- | |
| EP2379494A4 (de) | Oxidation alkylaromatischer verbindungen | |
| HK1154757A1 (en) | Salts and polymorphs of a tetracycline compound | |
| ZA201400281B (en) | Salts and polymorphs of a tetracycline compound | |
| AP3659A (en) | A novel formulation of meloxicam | |
| EP2249650A4 (de) | Anilinopyridine als fak-hemmer | |
| ZA201108648B (en) | A novel formulation of naproxen | |
| HK1161680A1 (en) | Pyrazolylaminopyridines as inhibitors of fak fak | |
| EP2195309A4 (de) | Polymorphe von esomeprazolsalzen | |
| IL197956A0 (en) | Polymorphs of nicotinic intermediates | |
| EP2638013A4 (de) | Neue polymorphe von pitavastatin-calcium | |
| IL248077A0 (en) | Formulations, salts and polymers of transnorsertraline and their uses | |
| EP2537832A4 (de) | Verfahren zur herstellung von (e)-methyl 2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylat | |
| DK2274543T3 (da) | Fordeler med en drejelig U-formet forbindelseskanal | |
| ZA201202859B (en) | Polymorphs of sorafeinib acid addition salts | |
| EP2376452A4 (de) | Neues polymorph aus atazanavir-sulfat | |
| WO2011076711A3 (en) | Polymorphs of salts of 4- [4- [ [4-chloro-3- (trifluoromethyl) phenyl] carbamoylamino] phenoxy] -n-methylpyridine - 2 - carboxamide | |
| IL257014A (en) | A novel formulation of meloxicam | |
| HU0900682D0 (en) | Appliance for supporting head of animals | |
| IL209326A0 (en) | Solid state forms of aliskiren compounds | |
| IL243320A0 (en) | Intermediates of teroarylpiperidine and piperazine derivatives | |
| UA13878S (uk) | Головка сиру |